Examkin

Question

Difficulty: HardPharmacologic Interventions

A 62-year-old female presents to the emergency department complaining of severe, crushing substernal chest pain radiating to her left arm, which started 22 hours ago while resting. She also reports progressive shortness of breath over the same period. Her past medical history is significant for hypertension, type 2 diabetes mellitus, and hyperlipidemia. Vital signs show a blood pressure of 155/92155/92 mmHg, heart rate of 112112/min, respiratory rate of 2424/min, and oxygen saturation of 89%89\% on room air. Physical examination reveals prominent jugular venous distention. Cardiac auscultation reveals an S3 gallop, and pulmonary auscultation demonstrates bilateral crackles extending to the mid-lung fields. An electrocardiogram shows 22 mm ST-segment depressions in leads V2-V5 and T-wave inversions in leads I and aVL. There are no ST-segment elevations. Laboratory studies reveal a markedly elevated high-sensitivity cardiac troponin T. In addition to supplemental oxygen and sublingual nitroglycerin, which of the following pharmacologic interventions should be ordered for this patient at this time? (Select all that apply)

  1. Chewable aspirin 325 mgAnswer
  2. Intravenous unfractionated heparinAnswer
  3. High-intensity oral atorvastatinAnswer
  4. D
    Intravenous metoprolol tartrate
  5. E
    Intravenous alteplase

Answer

The correct pharmacologic interventions to order immediately are chewable aspirin, intravenous unfractionated heparin, and high-intensity oral atorvastatin.
This patient is presenting with a Non-ST-Elevation Myocardial Infarction (NSTEMI) complicated by acute decompensated heart failure. The standard of care for early management of NSTEMI includes dual antiplatelet therapy (starting immediately with aspirin), therapeutic anticoagulation (such as unfractionated heparin) to prevent further thrombus formation, and a high-intensity statin (such as atorvastatin) for its pleiotropic plaque-stabilizing effects. These three interventions are indicated universally in NSTEMI unless specific absolute contraindications exist, none of which are present for these three drugs in this patient.

Step-by-Step Solution

1
Interpret the clinical presentation, electrocardiogram, and laboratory results.
The patient's ischemic chest pain, elevated cardiac troponin, and ST-segment depressions in the absence of ST elevations indicate a diagnosis of Non-ST-Elevation Myocardial Infarction (NSTEMI).
Establishing the precise type of acute coronary syndrome is necessary to activate the correct evidence-based treatment protocol.
2
Assess the patient's hemodynamic status and physical examination findings for concurrent complications.
The presence of severe hypoxia, an S3 gallop, jugular venous distention, and extensive pulmonary crackles firmly establishes a concurrent diagnosis of acute decompensated heart failure.
Identifying acute heart failure is critical because it fundamentally alters the safety profile of standard acute coronary syndrome medications.
3
Determine the appropriate combination of early pharmacologic interventions while avoiding contraindicated agents.
Standard NSTEMI therapy requires antiplatelet agents (aspirin), anticoagulation (heparin), and plaque stabilization (atorvastatin). Beta-blockers must be withheld due to the acute decompensated heart failure. Fibrinolytics must be withheld because they are contraindicated in NSTEMI.
Selecting the correct multi-drug regimen requires balancing the need to treat the acute ischemic event against the risk of worsening the patient's acute cardiogenic pulmonary edema and avoiding interventions known to cause harm in non-ST-elevation events.

Key Concept

Pharmacologic management of NSTEMI complicated by acute decompensated heart failure
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic